Hi duke
I agree with dx-1 being slim before ph 1 trials but because of DX.3’s ability to hold more payload it is bringing in a lot more than just cancer scenarios
The conferance this week we are attending is for other measures besides cancer potential cancer cures, at least the timing is right for this if we can have a successful GMP
”non dilutive funding’ was from potential partners/deals the Dr was talking about a couple of years ago, we all know why this stalled, if back on track at least it will spark up more interest and debate about partners and jV’s ect and this is exactly what investors want as to revive traction/volume and above all sentiment again
- Forums
- ASX - By Stock
- Ann: Presentation to highlight broader potential of Deoxymabs
Hi duke I agree with dx-1 being slim before ph 1 trials but...
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.46M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $950 | 118.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1039316 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1550008 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1039316 | 0.008 |
21 | 5953441 | 0.007 |
10 | 2287680 | 0.006 |
8 | 3155992 | 0.005 |
5 | 4324000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1550008 | 2 |
0.010 | 1610744 | 3 |
0.011 | 1610000 | 5 |
0.012 | 372407 | 3 |
0.013 | 990000 | 2 |
Last trade - 14.29pm 06/05/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online